Shenzhen Kangtai Biological Products Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 12.24%

Shenzhen Kangtai Biological Products Co Ltd (300601) has an Asset Resilience Ratio of 12.24% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.71 Billion

≈ $250.44 Million USD Cash + Short-term Investments

Total Assets

CN¥13.99 Billion

≈ $2.05 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Shenzhen Kangtai Biological Products Co Ltd's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Shenzhen Kangtai Biological Products Co to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Kangtai Biological Products Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Shenzhen Kangtai Biological Products Co .

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.71 Billion	12.24%
Total Liquid Assets	CN¥1.71 Billion	12.24%

Asset Resilience Insights

Moderate Liquidity: Shenzhen Kangtai Biological Products Co Ltd has 12.24% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Shenzhen Kangtai Biological Products Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shenzhen Kangtai Biological Products Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Shenzhen Kangtai Biological Products Co Ltd (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Shenzhen Kangtai Biological Products Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	11.98%	CN¥1.69 Billion ≈ $247.13 Million	CN¥14.10 Billion ≈ $2.06 Billion	-2.95pp
2024-12-31	14.93%	CN¥2.17 Billion ≈ $318.13 Million	CN¥14.56 Billion ≈ $2.13 Billion	+14.26pp
2023-12-31	0.66%	CN¥100.02 Million ≈ $14.64 Million	CN¥15.09 Billion ≈ $2.21 Billion	-2.53pp
2022-12-31	3.20%	CN¥440.83 Million ≈ $64.51 Million	CN¥13.79 Billion ≈ $2.02 Billion	-1.93pp
2021-12-31	5.13%	CN¥725.57 Million ≈ $106.17 Million	CN¥14.15 Billion ≈ $2.07 Billion	-17.36pp
2020-12-31	22.49%	CN¥2.16 Billion ≈ $315.37 Million	CN¥9.58 Billion ≈ $1.40 Billion	+17.96pp
2017-12-31	4.52%	CN¥100.00 Million ≈ $14.63 Million	CN¥2.21 Billion ≈ $323.50 Million	+2.85pp
2016-12-31	1.67%	CN¥26.80 Million ≈ $3.92 Million	CN¥1.60 Billion ≈ $234.26 Million	+0.17pp
2015-12-31	1.50%	CN¥20.00 Million ≈ $2.93 Million	CN¥1.33 Billion ≈ $195.18 Million	+0.68pp
2014-12-31	0.82%	CN¥11.00 Million ≈ $1.61 Million	CN¥1.34 Billion ≈ $196.39 Million	-0.49pp
2013-12-31	1.31%	CN¥14.50 Million ≈ $2.12 Million	CN¥1.11 Billion ≈ $161.97 Million	--

pp = percentage points

About Shenzhen Kangtai Biological Products Co Ltd

SHE:300601 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.05 Billion

CN¥14.02 Billion CNY

Market Cap Rank

#6016 Global

#1133 in China

Share Price

CN¥12.55

Change (1 day)

+0.00%

52-Week Range

CN¥10.97 - CN¥20.49

All Time High

CN¥148.10